PRKCA and breast cancer: Studies indicated that the activation of PLCβ, PKCα or c‐Src has a critical role in tumour growth, cell migration, invasiveness and metastasis in breast cancer, colon carcinoma, lung squamous cell carcinoma and hepatocellular carcinoma cells.42, 43, 44, 45